Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Cadiz – page 7

82 clinical trials in Cadiz, Spain across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Cadiz at a glance
82
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

82 trials in Cadiz

Open in trial search

Study on the Effects of MBS2320 for Patients with Idiopathic Pulmonary Fibrosis (IPF)

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:MBS2320
  • Sponsor:Modern Biosciences Limited

Prostate cancer

Not recruiting

Study of Apalutamide and Androgen Deprivation Therapy for Patients with High-Risk Prostate Cancer

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Apalutamide
  • Sponsor:Janssen Cilag International

Gingival bleeding+1

Not recruiting

Study on Tranexamic Acid Oral Solution for Preventing Bleeding in Patients on Blood Thinners Undergoing Tooth Extraction

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Tranexamic Acid
  • Sponsor:Hyloris Developments

Neoplasm malignant

Not recruiting

Study on Atezolizumab and Chemotherapy for Patients with Triple-Negative Breast Cancer

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:NSABP Foundation Inc.

Vitiligo

Not recruiting

Study on MK-6194 for Treating Adults with Non-Segmental Vitiligo

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:MK-6194
  • Sponsor:Merck Sharp & Dohme LLC

Insomnia+1

Not recruiting

Study on Daridorexant for Treating Insomnia in Patients with Insomnia and Nocturia

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Daridorexant
  • Sponsor:Idorsia Pharmaceuticals Ltd.

Study on Darolutamide and Androgen Deprivation Therapy for Men with Metastatic Hormone-Sensitive Prostate Cancer

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Darolutamide
  • Sponsor:Bayer AG

Study Comparing DZD9008 and Chemotherapy for First-Line Treatment in Patients with Advanced Non-Small Cell Lung Cancer with EGFR Exon 20 Mutation

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Dizal Pharmaceutical Co. Ltd.

Study Comparing Darolutamide and Androgen Deprivation Therapy to Placebo and Androgen Deprivation Therapy in Men with High-Risk Prostate Cancer Recurrence

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Darolutamide
  • Sponsor:Bayer AG

Marginal zone lymphoma+1

Not recruiting

Study Comparing Zanubrutinib, Obinutuzumab, and Rituximab with Lenalidomide and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Lenalidomide
  • Sponsor:BeOne Medicines AG

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Cadiz

What the registry says about research in the country

01 Oncology Research

Innovative clinical trials focusing on bladder cancer treatments, including studies of mitomycin C delivery and immunotherapy approaches. Research extends to pancreatic adenocarcinoma and triple-negative breast cancer, evaluating new therapeutic combinations.

  • Non-muscle invasive bladder cancer treatments
  • Neoadjuvant therapy for pancreatic cancer
  • Immunotherapy combinations

Studies are exploring both localized and advanced disease states with emphasis on improving survival rates.

02 Immunology and Allergies

Groundbreaking research in allergic conditions and autoimmune disorders, including studies on hidradenitis suppurativa and innovative immunotherapy approaches for allergic rhinitis.

  • Allergen-specific immunotherapy
  • Inflammatory skin conditions
  • Respiratory allergies

Trials aim to evaluate novel therapeutic agents and treatment protocols for chronic conditions.

03 Transplant Medicine

Studies focusing on improving outcomes in kidney transplantation, particularly addressing delayed graft function through innovative therapeutic approaches.

  • Prevention of graft rejection
  • Post-transplant complications
  • Novel immunosuppressive strategies

Research aims to enhance transplant success rates and reduce post-operative complications.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.